Yutrepia 106 MCG Inhalation Powder

RxCUI: 2714676
RxNorm name: Yutrepia 106 MCG Inhalation Powder
Display name: Yutrepia 106 MCG Inhalation Powder
Full name: Yutrepia 106 MCG Inhalation Powder
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Yutrepia	TREPROSTINIL	Liquidia Technologies, Inc.	e8f6d534-115c-440e-bdbb-b443a29bb468	2025-09-08	Warnings, Adverse reactions	Exact identifier rxcui: 2714676

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e8f6d534-115c-440e-bdbb-b443a29bb468	Yutrepia 106 MCG Inhalation Powder [PSN] · treprostinil 0.106 MG Inhalation Powder [Yutrepia] [SBD] · Yutrepia 0.106 MG Inhalation Powder [SY] · Yutrepia 106 MCG (as treprostinil sodium) Inhalation Powder [SY] · Yutrepia 106 MCG Inhalation Powder [SY]	5	3	These highlights do not include all the information needed to use YUTREPIA™ safely and effectively. See full prescribing information for YUTREPIA™ . YUTREPIA™ (treprostinil) inhalation powder, for oral inhalation Initial U.S. Approval: 2002	20250908